Oxytocin ameliorates cognitive impairments by attenuating excitation/inhibition imbalance of neurotransmitters acting on parvalbumin interneurons in a mouse model of sepsis-associated encephalopathy

Abstract

Inflammation plays a crucial role in the initiation and progression of sepsis and induces alterations in brain neurotransmission, thereby contributing to the development of sepsis-associated encephalopathy (SAE). Parvalbumin (PV) interneurons are pivotal contributors to cognitive processes and have been implicated in various central nervous system dysfunctions, including SAE. Oxytocin, known for its ability to augment the firing rate of gamma-aminobutyric acid (GABA)-ergic interneurons and directly stimulate inhibitory interneurons to enhance the tonic inhibition of pyramidal neurons, has prompted an investigation into its potential therapeutic effects on cognitive dysfunction in SAE. In the current study, we administered intranasal oxytocin to SAE mice induced by lipopolysaccharide. Behavioral assessments, including open field, Y-maze, and fear conditioning, were used to evaluate cognitive performance. Golgi staining revealed hippocampal synaptic deterioration, local field potential recordings showed weakened gamma oscillations, and immunofluorescence staining demonstrated decreased PV expression in the cornu ammonis 1 (CA1) region of the hippocampus following lipopolysaccharide treatment, all of which were alleviated by oxytocin administration. Furthermore, immunofluorescence staining of PV co-localization with vesicular glutamate transporter 1 or vesicular GABA transporter indicated a balanced excitation/inhibition effect of neurotransmitters on PV interneurons after oxytocin administration in the SAE mice, leading to an improved cognitive function. In conclusion, oxytocin treatment improved cognitive function by increasing the number of PV⁺ neurons in the hippocampal CA1 region, restoring the balance of excitatory/inhibitory synaptic transmission on PV interneurons, and enhancing hippocampal CA1 local field potential gamma oscillations. These findings suggest a potential mechanism underlying the beneficial effects of oxytocin in SAE.

Keywords

excitation/inhibition balance / oxytocin / cognitive / sepsis-associated encephalopathy

Fundings

This work was supported by grants from the general project of Nanjing Medical University Science and Technology Development Foundation (Grant No. NMUB20210112).

Acknowledgments

None.

References

[1] Bleck TP. Sepsis on the brain[J]. Crit Care Med, 2002, 30(5): 1176-1177. doi: 10.1097/00003246-200205000-00047

[2] Jeppsson B, Freund HR, Gimmon Z, et al. Blood-brain barrier derangement in sepsis: cause of septic encephalopathy?[J]. Am J Surg, 1981, 141(1): 136-142. doi: 10.1016/0002-9610(81)90026-X

[3] Cotena S, Piazza O. Sepsis-associated encephalopathy[J]. Transl Med UniSa, 2012, 2: 20-27.

[4] Wu X, Ji M, Yin X, et al. Reduced inhibition underlies early life LPS exposure induced-cognitive impairment: Prevention by environmental enrichment[J]. Int Immunopharmacol, 2022, 108: 108724. doi: 10.1016/j.intimp.2022.108724

[5] Lepousez G, Lledo PM. Odor discrimination requires proper olfactory fast oscillations in awake mice[J]. Neuron, 2013, 80(4): 1010-1024. doi: 10.1016/j.neuron.2013.07.025

[6] Iaccarino HF, Singer AC, Martorell AJ, et al. Gamma frequency entrainment attenuates amyloid load and modifies microglia[J]. Nature, 2016, 540(7632): 230-235. doi: 10.1038/nature20587

[7] Heusser AC, Poeppel D, Ezzyat Y, et al. Episodic sequence memory is supported by a theta-gamma phase code[J]. Nat Neurosci, 2016, 19(10): 1374-1380. doi: 10.1038/nn.4374

[8] Park K, Lee J, Jang HJ, et al. Optogenetic activation of parvalbumin and somatostatin interneurons selectively restores theta-nested gamma oscillations and oscillation-induced spike timing-dependent long-term potentiation impaired by amyloid β oligomers[J]. BMC Biol, 2020, 18(1): 7. doi: 10.1186/s12915-019-0732-7

[9] Ji M, Qiu L, Tang H, et al. Sepsis-induced selective parvalbumin interneuron phenotype loss and cognitive impairments may be mediated by NADPH oxidase 2 activation in mice[J]. J Neuroinflammation, 2015, 12(1): 182. doi: 10.1186/s12974-015-0401-x

[10] Gao R, Ji M, Gao D, et al. Neuroinflammation-induced downregulation of hippocampacal neuregulin 1-ErbB4 signaling in the parvalbumin interneurons might contribute to cognitive impairment in a mouse model of sepsis-associated encephalopathy[J]. Inflammation, 2017, 40(2): 387-400. doi: 10.1007/s10753-016-0484-2

[11] Ye C, Cheng M, Ma L, et al. Oxytocin nanogels inhibit innate inflammatory response for early intervention in Alzheimer's disease[J]. ACS Appl Mater Interfaces, 2022, 14(19): 21822-21835. doi: 10.1021/acsami.2c00007

[12] Jiang J, Zou Y, Xie C, et al. Oxytocin alleviates cognitive and memory impairments by decreasing hippocampal microglial activation and synaptic defects via OXTR/ERK/STAT3 pathway in a mouse model of sepsis-associated encephalopathy[J]. Brain Behav Immun, 2023, 114: 195-213. doi: 10.1016/j.bbi.2023.08.023

[13] Ripamonti S, Ambrozkiewicz MC, Guzzi F, et al. Transient oxytocin signaling primes the development and function of excitatory hippocampal neurons[J]. eLife, 2017, 6: e22466. doi: 10.7554/eLife.22466

[14] Owen SF, Tuncdemir SN, Bader PL, et al. Oxytocin enhances hippocampal spike transmission by modulating fast-spiking interneurons[J]. Nature, 2013, 500(7463): 458-462. doi: 10.1038/nature12330

[15] Crane JW, Holmes NM, Fam J, et al. Oxytocin increases inhibitory synaptic transmission and blocks development of long-term potentiation in the lateral amygdala[J]. J Neurophysiol, 2020, 123(2): 587-599. doi: 10.1152/jn.00571.2019

[16] Mühlethaler M, Charpak S, Dreifuss JJ. Contrasting effects of neurohypophysial peptides on pyramidal and non-pyramidal neurones in the rat hippocampus[J]. Brain Res, 1984, 308(1): 97-107. doi: 10.1016/0006-8993(84)90921-1

[17] Tiberiis BE, McLennan H, Wilson N. Neurohypophysial peptides and the hippocampus. II. Excitation of rat hippocampal neurones by oxytocin and vasopressin applied in vitro[J]. Neuropeptides, 1983, 4(1): 73-86. doi: 10.1016/0143-4179(83)90011-2

[18] Zaninetti M, Raggenbass M. Oxytocin receptor agonists enhance inhibitory synaptic transmission in the rat hippocampus by activating interneurons in stratum pyramidale[J]. Eur J Neurosci, 2000, 12(11): 3975-3984. doi: 10.1046/j.1460-9568.2000.00290.x

[19] Zhou T, Zhao L, Zhan R, et al. Blood-brain barrier dysfunction in mice induced by lipopolysaccharide is attenuated by dapsone[J]. Biochem Biophys Res Commun, 2014, 453(3): 419-424. doi: 10.1016/j.bbrc.2014.09.093

[20] Keinath AT, Nieto-Posadas A, Robinson JC, et al. DG-CA3 circuitry mediates hippocampal representations of latent information[J]. Nat Commun, 2020, 11(1): 3026. doi: 10.1038/s41467-020-16825-1

[21] Alkadhi KA. Cellular and molecular differences between area CA1 and the dentate gyrus of the hippocampus[J]. Mol Neurobiol, 2019, 56(9): 6566-6580. doi: 10.1007/s12035-019-1541-2

[22] Kohara K, Pignatelli M, Rivest AJ, et al. Cell type-specific genetic and optogenetic tools reveal hippocampal CA2 circuits[J]. Nat Neurosci, 2014, 17(2): 269-279. doi: 10.1038/nn.3614

[23] Hainmueller T, Bartos M. Parallel emergence of stable and dynamic memory engrams in the hippocampus[J]. Nature, 2018, 558(7709): 292-296. doi: 10.1038/s41586-018-0191-2

[24] Uchino S, Nakamura T, Nakamura K, et al. Real-time, two-dimensional visualization of ischaemia-induced glutamate release from hippocampal slices[J]. Eur J Neurosci, 2001, 13(4): 670-678. doi: 10.1046/j.1460-9568.2001.01430.x

[25] Wang X, Pal R, Chen X, et al. Genome-wide transcriptome profiling of region-specific vulnerability to oxidative stress in the hippocampus[J]. Genomics, 2007, 90(2): 201-212. doi: 10.1016/j.ygeno.2007.03.007

[26] Uysal N, Tugyan K, Aksu I, et al. Age-related changes in apoptosis in rat hippocampus induced by oxidative stress[J]. Biotech Histochem, 2012, 87(2): 98-104. doi: 10.3109/10520295.2011.556665

[27] Olufunmilayo EO, Gerke-Duncan MB, Holsinger RMD. Oxidative stress and antioxidants in neurodegenerative disorders[J]. Antioxidants (Basel), 2023, 12(2): 517. doi: 10.3390/antiox12020517

[28] Smith AS, Korgan AC, Young WS. Oxytocin delivered nasally or intraperitoneally reaches the brain and plasma of normal and oxytocin knockout mice[J]. Pharmacol Res, 2019, 146: 104324. doi: 10.1016/j.phrs.2019.104324

[29] Ji M, Lei L, Gao D, et al. Neural network disturbance in the medial prefrontal cortex might contribute to cognitive impairments induced by neuroinflammation[J]. Brain Behav Immun, 2020, 89: 133-144. doi: 10.1016/j.bbi.2020.06.001

[30] Gao Y, Wu X, Zhou Z, et al. Dysfunction of NRG1/ErbB4 signaling in the hippocampus might mediate long-term memory decline after systemic inflammation[J]. Mol Neurobiol, 2023, 60(6): 3210-3226. doi: 10.1007/s12035-023-03278-y

[31] Yamamoto J, Suh J, Takeuchi D, et al. Successful execution of working memory linked to synchronized high-frequency gamma oscillations[J]. Cell, 2014, 157(4): 845-857. doi: 10.1016/j.cell.2014.04.009

[32] Verret L, Mann EO, Hang GB, et al. Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model[J]. Cell, 2012, 149(3): 708-721. doi: 10.1016/j.cell.2012.02.046

[33] Martorell AJ, Paulson AL, Suk HJ, et al. Multi-sensory Gamma stimulation ameliorates Alzheimer's-associated pathology and improves cognition[J]. Cell, 2019, 177(2): 256-271. e22. doi: 10.1016/j.cell.2019.02.014

[34] Chen G, Zhang Y, Li X, et al. Distinct inhibitory circuits orchestrate cortical beta and gamma band oscillations[J]. Neuron, 2017, 96(6): 1403-1418. e6. doi: 10.1016/j.neuron.2017.11.033

[35] Conti F, Weinberg RJ. Shaping excitation at glutamatergic synapses[J]. Trends Neurosci, 1999, 22(10): 451-458. doi: 10.1016/S0166-2236(99)01445-9

[36] Cherubini E, Conti F. Generating diversity at GAB Aergic synapses[J]. Trends Neurosci, 2001, 24(3): 155-162. doi: 10.1016/S0166-2236(00)01724-0

[37] Eiden LE. The vesicular neurotransmitter transporters: current perspectives and future prospects[J]. FASEB J, 2000, 14(15): 2396-2400. doi: 10.1096/fj.00-0817rev

[38] Wilson NR, Kang J, Hueske EV, et al. Presynaptic regulation of quantal size by the vesicular glutamate transporter VGLUT1[J]. J Neurosci, 2005, 25(26): 6221-6234. doi: 10.1523/JNEUROSCI.3003-04.2005

[39] Zhang J, Ma L, Chang L, et al. A key role of the subdiaphragmatic vagus nerve in the depression-like phenotype and abnormal composition of gut microbiota in mice after lipopolysaccharide administration[J]. Transl Psychiatry, 2020, 10(1): 186. doi: 10.1038/s41398-020-00878-3

[40] Zhang J, Ma L, Wan X, et al. (R)-Ketamine attenuates LPS-induced endotoxin-derived delirium through inhibition of neuroinflammation[J]. Psychopharmacology (Berl), 2021, 238(10): 2743-2753. doi: 10.1007/s00213-021-05889-6

[41] Xue M, Atallah BV, Scanziani M. Equalizing excitation-inhibition ratios across visual cortical neurons[J]. Nature, 2014, 511(7511): 596-600. doi: 10.1038/nature13321

[42] Bartos M, Vida I, Jonas P. Synaptic mechanisms of synchronized gamma oscillations in inhibitory interneuron networks[J]. Nat Rev Neurosci, 2007, 8(1): 45-56. doi: 10.1038/nrn2044

[43] Gao R, Peterson EJ, Voytek B. Inferring synaptic excitation/inhibition balance from field potentials[J]. Neuroimage, 2017, 158: 70-78. doi: 10.1016/j.neuroimage.2017.06.078

[44] Young WS, Song J. Characterization of oxytocin receptor expression within various neuronal populations of the mouse dorsal hippocampus[J]. Front Mol Neurosci, 2020, 13: 40. doi: 10.3389/fnmol.2020.00040

[45] Maldonado PP, Nuno-Perez A, Kirchner JH, et al. Oxytocin shapes spontaneous activity patterns in the developing visual cortex by activating somatostatin interneurons[J]. Curr Biol, 2021, 31(2): 322-333. e5. doi: 10.1016/j.cub.2020.10.028

[46] Udakis M, Pedrosa V, Chamberlain SEL, et al. Interneuron-specific plasticity at parvalbumin and somatostatin inhibitory synapses onto CA1 pyramidal neurons shapes hippocampal output[J]. Nat Commun, 2020, 11(1): 4395. doi: 10.1038/s41467-020-18074-8

[47] Magnin E, Francavilla R, Amalyan S, et al. Input-specific synaptic location and function of the α5 GABA_A receptor subunit in the mouse CA1 hippocampal neurons[J]. J Neurosci, 2019, 39(5): 788-801. doi: 10.1523/JNEUROSCI.0567-18.2018

[48] Carter CS, Kenkel WM, MacLean EL, et al. Is oxytocin "nature's medicine"?[J]. Pharmacol Rev, 2020, 72(4): 829-861. doi: 10.1124/pr.120.019398

[49] Yuan L, Liu S, Bai X, et al. Oxytocin inhibits lipopolysaccharide-induced inflammation in microglial cells and attenuates microglial activation in lipopolysaccharide-treated mice[J]. J Neuroinflammation, 2016, 13(1): 77. doi: 10.1186/s12974-016-0541-7